ARROWHEAD PHARMACEUTICALS, INC.: 10-K filed 2011-12-20

Name: ARROWHEAD PHARMACEUTICALS, INC.: 10-K filed 2011-12-20
Creator: ARROWHEAD PHARMACEUTICALS, INC.

What ARROWHEAD PHARMACEUTICALS, INC. reported in its annual report filed 2011-12-20 (fiscal FY 2011): 36 published measures, 98 facts as tagged in accession 0001193125-11-347334.

This filing

Form: 10-K (annual report)
Filed: 2011-12-20
Fiscal period: fiscal FY 2011
Accession: 0001193125-11-347334 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARROWHEAD PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	15,888,563	USD
At 2010-09-30	12,354,542	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-09-30	12,791,106	USD
At 2010-09-30	9,045,702	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	7,507,389	USD
At 2010-09-30	6,847,162	USD
At 2009-09-30	2,020,224	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	-3,128,885	USD	365
2003-05-07 to 2011-09-30	-113,707,792	USD	3069
2009-10-01 to 2010-09-30	-5,774,048	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	9,674	USD	365
2003-05-07 to 2011-09-30	3,565,599	USD	3069

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	296,139	USD	365
2003-05-07 to 2011-09-30	3,991,959	USD	3069

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-09-30	-113,871,752	USD
At 2010-09-30	-110,742,867	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	7,181,121	shares	365
2009-10-01 to 2010-09-30	6,434,245	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	7,830,407	shares	365
2009-10-01 to 2010-09-30	6,434,245	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	-0.44	USD/shares	365
2009-10-01 to 2010-09-30	-0.9	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	-0.4	USD/shares	365
2009-10-01 to 2010-09-30	-0.9	USD/shares	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-09-30	25,437	USD
At 2010-09-30	141,269	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	1,376,921	USD	365
2003-05-07 to 2011-09-30	12,340,064	USD	3069
2009-10-01 to 2010-09-30	1,424,293	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	-9,830,266	USD	365
2003-05-07 to 2011-09-30	-96,126,802	USD	3069
2009-10-01 to 2010-09-30	-5,832,821	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-09-30	9,861,174	USD
At 2010-09-30	8,131,775	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-09-30	2,581,949	USD
At 2010-09-30	4,276,246	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-09-30	576,809	USD
At 2010-09-30	681,563	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2010-09-30	58,864	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	10,126,405	USD	365
2003-05-07 to 2011-09-30	100,118,761	USD	3069
2009-10-01 to 2010-09-30	5,832,821	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	3,277,760	USD	365
2003-05-07 to 2011-09-30	40,428,729	USD	3069
2009-10-01 to 2010-09-30	529,601	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-09-30	8,642,286	shares
At 2010-09-30	7,172,014	shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2011-09-30	12,564,168	USD
At 2010-09-30	8,078,296	USD
At 2009-09-30	4,857,936	USD
At 2008-09-30	12,302,609	USD
At 2007-09-30	26,456,577	USD
At 2006-09-30	31,605,644	USD
At 2005-09-30	28,026,657	USD
At 2004-09-30	11,227,149	USD
At 2003-09-30	1,419,762	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2011-09-30	365,801	USD
At 2010-09-30	1,317,673	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2011-09-30	340,364	USD
At 2010-09-30	1,176,404	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-09-30	6,001,952	USD
At 2010-09-30	4,081,498	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-09-30	135,660	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-09-30	864,511	USD
At 2010-09-30	494,736	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-09-30	110,818	USD
At 2010-09-30	353,930	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	-8,785,008	USD	365
2003-05-07 to 2011-09-30	-88,704,308	USD	3069
2009-10-01 to 2010-09-30	-4,311,987	USD	365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	-3,492,399	USD	365
2003-05-07 to 2011-09-30	-131,542,282	USD	3069
2009-10-01 to 2010-09-30	-6,957,038	USD	365
2008-10-01 to 2009-09-30	-19,308,392	USD	365
2007-10-01 to 2008-09-30	-27,241,639	USD	366
2006-10-01 to 2007-09-30	-30,712,947	USD	365
2005-10-01 to 2006-09-30	-19,961,961	USD	365
2004-10-01 to 2005-09-30	-6,733,427	USD	365
2003-10-01 to 2004-09-30	-751,255	USD	366
2002-10-01 to 2003-09-30	-95,238	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	3,821,550	USD	365
2003-05-07 to 2011-09-30	25,590,815	USD	3069
2009-10-01 to 2010-09-30	2,490,725	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	267,977	USD	365
2003-05-07 to 2011-09-30	5,660,311	USD	3069
2009-10-01 to 2010-09-30	277,650	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	241,808	USD	365
2003-05-07 to 2011-09-30	1,781,944	USD	3069
2009-10-01 to 2010-09-30	241,808	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	1,045,258	USD	365
2003-05-07 to 2011-09-30	7,422,494	USD	3069
2009-10-01 to 2010-09-30	1,520,834	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	4,507,389	USD	365
2003-05-07 to 2011-09-30	95,294,780	USD	3069
2009-10-01 to 2010-09-30	12,165,156	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2010-10-01 to 2011-09-30	157,079	USD	365
2003-05-07 to 2011-09-30	206,434	USD	3069
2009-10-01 to 2010-09-30	-203,253	USD	365

Inspect the source

Entity: ARROWHEAD PHARMACEUTICALS, INC. / CIK 0000879407
Captured: 2026-09-20T05:01:27.924Z
SEC response SHA-256: df8855dae0055b71bd49c85d7ebc47f72ea6d71536d6bfd857bed2fe95364863

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000879407.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))